SystImmune, Inc. Announces the Presentation of Breast Cancer Clinical Trial Results at the 2023 San Antonio Breast Cancer Conference and US Clinical Trial Developments
SystImmune, Inc (SystImmune), a clinical-stage biopharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) authorized the company to proceed with the planned clinical study of the HER2-specific HIRE platform ADC, BL-M07D1, in the Investigational New Drug (IND) application…
Mission Therapeutics granted MHRA Clinical Trial Authorisation (CTA) for MTX325 for the treatment of Parkinson’s Disease
Mission Therapeutics (“Mission” or the “Company”), a clinical-stage biotech developing first-in-class therapeutics targeting mitophagy, today announces that the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) has granted clinical trial authorisation (CTA) for Mission to commence its multi-part, adaptive Phase…
Densitas® Selects CancerIQ to Power Lifetime Risk, Patient Adherence as Part of its Industry Leading Mammography Quality AI Platform
Densitas Inc., a global leader in artificial intelligence solutions for breast cancer screening, today announced a partnership with CancerIQ, a precision cancer prevention platform, to expand its offering to include CancerIQ’s Tyrer-Cuzick 8 risk calculator, as well as its care management and…
Military Roots Run Deep Through Family Care Center’s Commitment to Breaking the Stigma Around Mental Health
Every year, approximately 200,000 active-duty servicemen and women return to civilian life. Transitions for Veterans can be especially challenging due to shifting from the collective culture of military service to a more individualized role in society. In fact, studies indicate…
Child Help Foundation Inaugurated Arogya Sadan – A Hope for Patients Battling Thalassemia
Child Help Foundation (CHF), a pan-India non-profit child-centric organization, inaugurated the project ‘Arogya Sadan’ in the month of August. In a city, as expensive as Mumbai, the harsh reality is that most underprivileged families simply cannot afford the financial burden…
Syra Health Announces the Launch of Syrenity, an AI-backed Mental Health Product for Organizations Offering Mental Health Workforce Solutions
Syra Health Corp. (NASDAQ: SYRA) (“Syra Health” or the “Company”), a healthcare company with a mission to improve healthcare by providing innovative services and technology solutions, announced today the launch of Syrenity, a mental health product that proactively identifies the negative…
EAACI Pediatric Allergy and Asthma Meeting 2023: Shaping the Future of Pediatric Allergy and Asthma Care
The Organizing Committee is thrilled to announce the eagerly anticipated EAACI Pediatric Allergy and Asthma Meeting (PAAM) 2023, scheduled to take place from 2nd to 4th November 2023. This event will bring together esteemed experts from around the world to…
ThirdEye Announces $100M AI/MR Partnership with Japan’s OmGeneum to Radically Improve Medical Industry
ThirdEye, a leading provider of digital end-to-end ecosystem of Artificial Intelligence/Mixed Reality (AI/MR) products, announces today a multi-year contract with OmGeneum., a major Japanese regenerative bioengineering company, to converge ThirdEye’s AI powered smart glasses, customized AI/MR software applications with OmGeneum’s…
Hand to Hold® to host National NICU Mental Health Conference to help improve the long-term outcomes of babies
Hand to Hold, a national nonprofit that provides early intervention mental health support for Neonatal Intensive Care Unit (NICU) and bereaved parents will host its National NICU Mental Health Conference November 1 – November 2. This two-day conference for NICU…
New drug class prevents key ageing mechanism in organ transplants
A novel study has shown that Senolytics, a new class of drugs, have the potential to prevent the transfer of senescence, a key mechanism of ageing, in recipients of older donor organs. The pioneering research, presented today at the European…
